Pasar al contenido principal

DESARROLLO DE BIOMARCADORES DE CONSUMO Y DE EFECTO DE UN PATRON DE ALIMENTACION MEDITERRANEA EN LA PREVENCION DE LA ENFERMEDAD CARDIOVASCULAR. UNA APROXIMACION METABOLOMICA.

AGL2009-13906-C02-01

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2009
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario UNIVERSIDAD DE BARCELONA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery of human urinary biomarkers of aronia-citrus juice intake by HPLC-q-TOF-based metabolomic approach

  • Llorach, Rafael
  • Medina Escudero, Sonia
  • García-Viguera, Cristina
  • Zafrilla, Pilar
  • Abellán, José
  • Jauregui, Olga
  • Tomás Barberán, Francisco
  • Gil-Izquierdo, Ángel
  • Andrés-Lacueva, Cristina
Metabolomics has emerged in the field of food and nutrition sciences as a powerful tool for doing profiling approaches. In this context, HPLC-q-TOF-based metabolomics approach was applied to unveil changes in the urinary metabolome in human subjects (n = 51, 23 men and 28 women) after regular aronia-citrus juice (AC-juice) intake (250 mL/day) during 16 weeks compared to individuals given a placebo beverage. Samples were analyzed by HPLC-q-TOF followed by multivariate data analysis (orthogonal signal filtering-partial least square discriminant analysis) that discriminated relevant mass features related to AC-juice intake. The results showed that biomarkers of AC-juice intake including metabolites coming from metabolism of food components as proline betaine, ferulic acid, and two unknown mercapturate derivatives were identified. Discovery of new biomarkers of food intake will help in the building up of the food metabolome and facilitate future insights into the mechanisms of action of dietary components in population health, The authors are grateful to the National funding agencies through the Project CSD007-0063 (CONSOLIDER-INGENIO 2010 ‘Fun-C-Food', AGL2009-13906-C02-01 AGL2011-23690 and CSIC 201170E041), Spanish Ministry of Economy and Competitiveness. R.Ll. thanks the “Ramon y Cajal ́” program of the Spanish Ministry of Science and Innovation (MICINN) and Fondo Social Europeo (FSE) (RYC-2010-07334). SME was granted a predoctoral CSIC-JAE fellowship, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Does the Mediterranean diet counteract the adverse effects of abdominal adiposity?

  • Eguaras, S.
  • Toledo, E.
  • Buil-Cosiales, P.
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Gutiérrez-Bedmar, M.
  • Santos-Lozano, J. M.
  • Arós, Fernando
  • Fiol, Miquel
  • Fitó, Montserrat
  • Ros, Emilio
  • Serra-Majem, Lluis
  • Pintó, Xavier
  • Martínez, J. Alfredo
  • Sorlí, José V.
  • Muñoz, María A.
  • Basora, Josep
  • Estruch, Rramón
  • Martínez-González, Miguel Ángel
  • PREDIMED Investigators
[Background and aim] We tested the hypothesis that an intervention with a Mediterranean diet (MeDiet) could mitigate the well-known harmful effects of abdominal obesity on cardiovascular health., [Methods and results] We assessed the relationship between baseline waist-to-height ratio (WHtR) and major cardiovascular events during a median follow-up of 4.8 years in the Prevention with Mediterranean Diet (PREDIMED) randomized primary prevention trial, which tested a MeDiet against a control diet (advice on a low-fat diet). We also examined whether the MeDiet intervention was able to counteract the detrimental cardiovascular effects of an increased WHtR. The trial included 7447 participants (55–80 years old, 57% women) at high cardiovascular risk but free of cardiovascular disease (CVD) at enrollment., An increased risk of CVD events (myocardial infarction, stroke, or cardiovascular death) was apparent for the highest versus the lowest quartile of WHtR (multivariable-adjusted hazard ratio: 1.98) (95% confidence interval: 1.10–3.57; linear trend: p = 0.019) only in the control-diet group, but not in the two groups allocated to intervention with MeDiet (p for interaction = 0.034). This apparent interaction suggesting that the intervention counterbalanced the detrimental cardiovascular effects of adiposity was also significant for body mass index (BMI) (p = 0.01) and waist circumference (p = 0.043)., [Conclusions] The MeDiet may counteract the harmful effects of increased adiposity on the risk of CVD., Supported by the official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII), through specific grants (RTIC G03/140; RTIC-RD 06/0045, to Prof. Martínez-González and CIBERobn), and by Fondo de Investigación Sanitaria–ISCIII (PI04-2239, PI05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI10/02658, PI11/01647, and P11/02505), Ministerio Ciencia e Innovación (AGL-2009-13906-C02 and AGL2010-22319-C03), Fundación Mapfre 2010, Consejería Salud Junta de Andalucía (PI0105/2007), Health Department of Catalonia, Generalitat Valenciana (ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, and CS2011-AP-042), and Regional Government of Navarra (P27/2011). ET is supported by a Rio Hortega post-residency fellow of the ISCIII., Peer reviewed